市場調査レポート

商品コード

1701969

ウィメンズヘルス診断市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033

出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 438,093円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 584,173円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 730,253円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

ウィメンズヘルス診断市場の世界市場規模は2024年に311億米ドルに達しました。今後、IMARC Groupは、2033年には542億米ドルに達し、2025年から2033年にかけて6.4％の成長率（CAGR）を示すと予測しています。同市場は、慢性疾患や生活習慣病と診断される人の増加、診断サービスにおける著しい技術開拓、政府や公的機関による数多くのキャンペーンやイニシアチブを通じた女性の健康に対する意識の高まり、ポイントオブケア診断の受容率の上昇、遠隔医療や遠隔診断産業の急成長によって推進されています。

ウィメンズヘルス診断は、女性患者の様々な生物学的・心理社会的状態の診断に役立ちます。性・膣の問題や妊娠合併症に対処し、骨粗鬆症、更年期障害、乳がんや子宮頸がんなどの脅威となる疾患の管理を支援します。生検、超音波検査、化学療法、磁気共鳴画像法（MRI）など、一連の高度な臨床検査、ツール、手技を駆使しています。現在、いくつかの医療診断センターは、女性に影響を及ぼすまれな疾患や状態の診断と管理を強化するために、広範な臨床検査ソリューションを提供しています。

ウィメンズヘルス診断市場傾向：

女性の全体的な幸福に影響を与える健康問題の有病率の上昇は、市場にプラスの影響を与える主な要因の一つです。さらに、健康意識の高まりと早期診断の利点に関する意識の高まりが、世界中でポイントオブケア（POC）ウィメンズヘルス診断の需要を喚起しています。これとは別に、ストレスの多いライフスタイルやアルコール・薬物摂取の増加による不妊率の上昇が、妊娠合併症に対処し、より健康的な生活を確保するための女性用健康診断の必要性を高めています。さらに、更年期は心血管疾患や尿失禁を含む特定の病状の開発リスクを高める可能性があるため、50歳以上の女性人口の大幅な増加が市場の成長に寄与しています。これに加えて、いくつかの調査では、女性はホルモンの変化時にうつ病や不安障害などの精神疾患を経験する可能性が高いという結論が出ています。このことは、女性の精神的健康を改善するために多くの国の保健機関が行っているいくつかの取り組みと相まって、世界中で市場の成長を促進しています。

本レポートで扱う主な質問

2024年におけるウィメンズヘルス診断市場の世界市場規模は？
2025-2033年における世界のウィメンズヘルス診断市場の予想成長率は？
世界のウィメンズヘルス診断市場を牽引する主要因は何か？
世界のウィメンズヘルス診断市場に対するCOVID-19の影響は？
世界のウィメンズヘルス診断市場のタイプ別内訳は？
世界のウィメンズヘルス診断市場の用途別内訳は？
世界のウィメンズヘルス診断市場のエンドユーザー別内訳は？
世界のウィメンズヘルス診断市場における主要地域は？
世界のウィメンズヘルス診断市場における主要プレイヤー/企業は？

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第10章 SWOT分析

概要
強み
弱み
機会
脅威

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第13章価格分析

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Abbott Laboratories
- Becton Dickinson and Company
- bioMerieux SA
- Cardinal Health Inc.
- Cook Group Incorporated
- F. Hoffmann-La Roche AG
- General Electric Company
- Hologic Inc.
- Koninklijke Philips N.V.
- Perkinelmer Inc.
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.

図表

List of Figures

Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2024
Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2024
Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2024
Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2024
Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2024
Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
Table 7: Global: Women's Health Diagnostics Market: Key Players

Product Code: SR112025A4956

The global women's health diagnostics market size reached USD 31.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 54.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women's health through numerous campaigns and initiatives by the governments and public organizations, increasing acceptance rate of point-of-care diagnostics, and rapid growth in telemedicine and remote diagnostics industry.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

Breakup by Type:

Diagnostic Devices
Biopsy Device
Imaging and Monitoring Devices
Accessories and Consumables
Diagnostic Tests
Breast Cancer Testing
PAP Smear and HPV Test
Pregnancy Testing and Ovulation Testing
Others

Breakup by Application:

Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others

Breakup by End User:

Hospital and Diagnostics Centers
Home Care

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1.What was the size of the global women's health diagnostics market in 2024?
2.What is the expected growth rate of the global women's health diagnostics market during 2025-2033?
3.What are the key factors driving the global women's health diagnostics market?
4.What has been the impact of COVID-19 on the global women's health diagnostics market?
5.What is the breakup of the global women's health diagnostics market based on the type?
6.What is the breakup of the global women's health diagnostics market based on the application?
7.What is the breakup of the global women's health diagnostics market based on the end user?
8.What are the key regions in the global women's health diagnostics market?
9.Who are the key players/companies in the global women's health diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Diagnostic Devices
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Biopsy Device
  - 6.1.2.2 Imaging and Monitoring Devices
  - 6.1.2.3 Accessories and Consumables
- 6.1.3 Market Forecast
6.2 Diagnostic Tests
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Breast Cancer Testing
  - 6.2.2.2 PAP Smear and HPV Test
  - 6.2.2.3 Pregnancy Testing and Ovulation Testing
  - 6.2.2.4 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Breast Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Infectious Disease Testing
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Osteoporosis Testing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Pregnancy and Fertility Testing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Sexually Transmitted Disease Testing
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by End User

8.1 Hospital and Diagnostics Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Home Care
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Becton Dickinson and Company
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 bioMerieux SA
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Cardinal Health Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Cook Group Incorporated
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 F. Hoffmann-La Roche AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 General Electric Company
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Hologic Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Koninklijke Philips N.V.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Perkinelmer Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Quest Diagnostics Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Siemens AG
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis
- 14.3.13 Thermo Fisher Scientific Inc.
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

ウィメンズヘルス診断市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033

ウィメンズヘルス診断市場傾向：

本レポートで扱う主な質問

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のウィメンズヘルス診断市場

第6章 市場内訳：タイプ別

第7章 市場内訳：用途別

第8章 市場内訳：エンドユーザー別

第9章 市場内訳：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢